Orudis
NDC 28595-031, Ketoprofen, capsule, from Allegis Pharmaceuticals, Inc..
- Product NDC
- 28595-031
- Status
- Listed
- Labeler
- Allegis Pharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074014
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/28595-031 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- KETOPROFEN75 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 28595-031-60 | 28595003160 | 60 CAPSULE in 1 BOTTLE (28595-031-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 28595-031 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/28595-031 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 28595-031. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.